Nanologica AB (NICA) - Total Liabilities

Latest as of December 2025: Skr65.47 Million SEK ≈ $7.05 Million USD

Based on the latest financial reports, Nanologica AB (NICA) has total liabilities worth Skr65.47 Million SEK (≈ $7.05 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Nanologica AB (NICA) cash conversion ratio to assess how effectively this company generates cash.

Nanologica AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Nanologica AB's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Nanologica AB's assets to evaluate the company's liquid asset resilience ratio.

Nanologica AB Competitors by Total Liabilities

The table below lists competitors of Nanologica AB ranked by their total liabilities.

Company	Country	Total Liabilities
Vestand Inc. NASDAQ:VSTD	USA	$14.38 Million
Avricore Health Inc V:AVCR	Canada	CA$35.88K
Tarapur Transformers Limited NSE:TARAPUR	India	Rs110.87 Million
Davis Commodities Limited Ordinary Shares NASDAQ:DTCK	USA	$26.53 Million
Hubify Ltd AU:HFY	Australia	AU$3.73 Million
Maple Peak Investments Inc V:MAP	Canada	CA$45.57K
Mint Corp V:MIT	Canada	CA$888.36K
Auction Technology Group PLC LSE:ATG	UK	GBX250.77 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Nanologica AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Nanologica AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanologica AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanologica AB (2012–2025)

The table below shows the annual total liabilities of Nanologica AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr65.47 Million ≈ $7.05 Million	-5.10%
2024-12-31	Skr68.99 Million ≈ $7.42 Million	-13.03%
2023-12-31	Skr79.33 Million ≈ $8.54 Million	-2.49%
2022-12-31	Skr81.36 Million ≈ $8.76 Million	+74.13%
2021-12-31	Skr46.72 Million ≈ $5.03 Million	-12.48%
2020-12-31	Skr53.38 Million ≈ $5.74 Million	+39.87%
2019-12-31	Skr38.16 Million ≈ $4.11 Million	+259.34%
2018-12-31	Skr10.62 Million ≈ $1.14 Million	-55.70%
2017-12-31	Skr23.98 Million ≈ $2.58 Million	+143.71%
2016-12-31	Skr9.84 Million ≈ $1.06 Million	+14.02%
2015-12-31	Skr8.63 Million ≈ $928.58K	-24.54%
2014-12-31	Skr11.43 Million ≈ $1.23 Million	+252.85%
2013-12-31	Skr3.24 Million ≈ $348.74K	+20.11%
2012-12-31	Skr2.70 Million ≈ $290.36K	--

About Nanologica AB

ST:NICA Sweden Biotechnology

Market Cap

$5.12 Million

Skr47.60 Million SEK

Market Cap Rank

#28320 Global

#640 in Sweden

Share Price

Skr0.53

Change (1 day)

+0.75%

52-Week Range

Skr0.35 - Skr1.98

All Time High

Skr19.15